MedTrace Logo

Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients

NCT04953065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2024-05-09

No results posted yet for this study

Summary

The current study primarily aims to determine the status of vaccination in enrolled cancer patients and identify barriers to coronavirus disease 2019 (COVID-19) vaccination in cancer patients who have not been vaccinated. Secondary objectives include determining the rate of vaccination in those who have ever been COVID-19 positive and those who have never been COVID-19 positive. The study team also seeks to determine factors associated with vaccine-acceptance and vaccine-hesitancy in the adult cancer population, identify side effects of COVID-19 vaccines in vaccinated cancer patients and to examine the effect of COVID-19 vaccination on overall clinical outcome in cancer patients. The study team will be conducting telephone interviews/surveys with up to130 adult cancer patients for data collection.

Conditions

  • Malignancies Multiple

Interventions

OTHER

COVID-19 vaccine hesitancy and acceptance survey

Participants will be provided with a COVID-19 vaccine hesitancy and acceptance survey developed by the study team.

Sponsors & Collaborators

  • Monika Joshi

    lead OTHER

Principal Investigators

  • Monika Joshi, MD · Penn State Cancer Institute

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953065 on ClinicalTrials.gov